Regentatlantic Capital Has Decreased Its Metlife (MET) Holding; Haverford Trust Company Lowered Its Cvs Health (CVS) Position

December 18, 2017 - By Ellis Scott

Haverford Trust Company decreased Cvs Health Corporation (CVS) stake by 0.39% reported in 2017Q2 SEC filing. Haverford Trust Company sold 4,114 shares as Cvs Health Corporation (CVS)’s stock declined 4.23%. The Haverford Trust Company holds 1.06 million shares with $85.26M value, down from 1.06 million last quarter. Cvs Health Corporation now has $74.04 billion valuation. The stock increased 3.22% or $2.28 during the last trading session, reaching $73.08. About 14.33 million shares traded or 57.52% up from the average. CVS Health Corporation (NYSE:CVS) has declined 24.40% since December 18, 2016 and is downtrending. It has underperformed by 41.10% the S&P500.

Regentatlantic Capital Llc decreased Metlife Inc (MET) stake by 9.48% reported in 2017Q2 SEC filing. Regentatlantic Capital Llc sold 14,859 shares as Metlife Inc (MET)’s stock declined 4.70%. The Regentatlantic Capital Llc holds 141,813 shares with $7.79 million value, down from 156,672 last quarter. Metlife Inc now has $54.10 billion valuation. The stock decreased 2.06% or $1.08 during the last trading session, reaching $51.41. About 15.46 million shares traded or 274.60% up from the average. MetLife, Inc. (NYSE:MET) has risen 13.92% since December 18, 2016 and is uptrending. It has underperformed by 2.78% the S&P500.

Analysts await CVS Health Corporation (NYSE:CVS) to report earnings on February, 8. They expect $1.90 earnings per share, up 11.11% or $0.19 from last year’s $1.71 per share. CVS’s profit will be $1.92B for 9.62 P/E if the $1.90 EPS becomes a reality. After $1.50 actual earnings per share reported by CVS Health Corporation for the previous quarter, Wall Street now forecasts 26.67% EPS growth.

Since August 16, 2017, it had 0 insider purchases, and 7 selling transactions for $58.32 million activity. 85,743 shares were sold by Roberts Jonathan C, worth $7.13M on Monday, September 18. Foulkes Helena sold $3.22 million worth of CVS Health Corporation (NYSE:CVS) on Friday, September 15. Moriarty Thomas M sold 90,267 shares worth $7.19M. MERLO LARRY J also sold $20.03 million worth of CVS Health Corporation (NYSE:CVS) on Wednesday, August 23. Denton David M also sold $18.88 million worth of CVS Health Corporation (NYSE:CVS) shares. 2,500 shares were sold by SWIFT RICHARD J, worth $199,050.

Among 25 analysts covering CVS Health (NYSE:CVS), 17 have Buy rating, 0 Sell and 8 Hold. Therefore 68% are positive. CVS Health had 58 analyst reports since July 22, 2015 according to SRatingsIntel. The stock of CVS Health Corporation (NYSE:CVS) earned “Hold” rating by Jefferies on Wednesday, August 16. The rating was initiated by Robert W. Baird on Friday, January 22 with “Outperform”. The firm has “Buy” rating by UBS given on Thursday, October 6. Mizuho maintained CVS Health Corporation (NYSE:CVS) on Wednesday, November 9 with “Buy” rating. JP Morgan maintained the stock with “Overweight” rating in Monday, November 2 report. Barclays Capital reinitiated the stock with “Overweight” rating in Thursday, March 10 report. The rating was maintained by Citigroup with “Neutral” on Thursday, August 17. Needham maintained the shares of CVS in report on Friday, September 8 with “Hold” rating. The stock of CVS Health Corporation (NYSE:CVS) has “Neutral” rating given on Thursday, December 17 by Goldman Sachs. Leerink Swann maintained CVS Health Corporation (NYSE:CVS) on Tuesday, November 21 with “Buy” rating.

Investors sentiment decreased to 0.88 in 2017 Q2. Its down 0.04, from 0.92 in 2017Q1. It dived, as 84 investors sold CVS shares while 559 reduced holdings. 108 funds opened positions while 483 raised stakes. 803.96 million shares or 0.96% less from 811.73 million shares in 2017Q1 were reported. Wafra Invest Advisory Grp Ny has 0.03% invested in CVS Health Corporation (NYSE:CVS). Weitz Investment owns 0.39% invested in CVS Health Corporation (NYSE:CVS) for 113,291 shares. Seaward Partnership, Massachusetts-based fund reported 130,028 shares. The Ohio-based Private Trust Na has invested 0.62% in CVS Health Corporation (NYSE:CVS). Factory Mutual owns 1.42M shares or 1.32% of their US portfolio. Raub Brock Cap Mngmt Lp stated it has 176,875 shares. Diversified Trust owns 4,683 shares. Autus Asset Mgmt Ltd Liability Com holds 0.11% or 6,736 shares in its portfolio. Invest House Limited Liability Company reported 51,865 shares. Guardian LP accumulated 95,040 shares. First Company invested in 0.23% or 23,546 shares. Suntrust Banks invested in 551,778 shares. Intll Value Advisers Ltd Limited Liability Company holds 2.27 million shares or 5.65% of its portfolio. 597,700 were accumulated by Honeywell Interest Inc. Ferguson Wellman Cap has invested 0.02% in CVS Health Corporation (NYSE:CVS).

Haverford Trust Company increased Mondelez International Inc Cl A (NASDAQ:MDLZ) stake by 83,309 shares to 1.30 million valued at $56.16M in 2017Q2. It also upped Berkshire Hathaway Inc Del Cl B (BRKB) stake by 3,475 shares and now owns 13,846 shares. Wisdomtree Japan Hedged Equity Fund (DXJ) was raised too.

Analysts await MetLife, Inc. (NYSE:MET) to report earnings on February, 7. They expect $1.12 EPS, down 17.04% or $0.23 from last year’s $1.35 per share. MET’s profit will be $1.18 billion for 11.48 P/E if the $1.12 EPS becomes a reality. After $1.09 actual EPS reported by MetLife, Inc. for the previous quarter, Wall Street now forecasts 2.75% EPS growth.

Among 15 analysts covering MetLife (NYSE:MET), 8 have Buy rating, 1 Sell and 6 Hold. Therefore 53% are positive. MetLife had 45 analyst reports since July 31, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Wednesday, August 9 by Argus Research. The rating was maintained by Wells Fargo on Wednesday, August 2 with “Buy”. On Monday, July 24 the stock rating was initiated by J.P. Morgan with “Hold”. The firm has “Buy” rating by Deutsche Bank given on Monday, January 23. As per Tuesday, January 5, the company rating was downgraded by Citigroup. The stock has “Mkt Perform” rating by FBR Capital on Monday, November 28. The firm earned “Neutral” rating on Friday, October 7 by Credit Suisse. The rating was maintained by Wells Fargo on Friday, May 5 with “Buy”. The firm has “Buy” rating given on Tuesday, September 5 by RBC Capital Markets. The rating was maintained by Wells Fargo on Tuesday, October 3 with “Buy”.

Regentatlantic Capital Llc increased Hewlett Packard Enterprise C stake by 34,813 shares to 425,271 valued at $7.06M in 2017Q2. It also upped Exelon Corp (NYSE:EXC) stake by 67,175 shares and now owns 218,258 shares. Prudential Finl Inc (NYSE:PRU) was raised too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.